This article reviews the definition of HCPs, risks posed by HCPs, regulatory concerns, commonly accepted ELISA methods for HCP measurement and their limitations, and orthogonal methods available for HCP characterization.
This article reviews the definition of HCPs, risks posed by HCPs, regulatory concerns, commonly accepted ELISA methods for HCP measurement and their limitations, and orthogonal methods available for HCP characterization.
This article reviews the definition of HCPs, risks posed by HCPs, regulatory concerns, commonly accepted ELISA methods for HCP measurement and their limitations, and orthogonal methods available for HCP characterization.
This report describes the first known attempt at quantifying the success of such processes in inducing nucleation on a 56–m2 freeze dryer operating at a load of 195,960 vials.
A successful QPS acts as a single point of contact for consistent product quality oversight.
A well-designed comparability study can demonstrate the performance and advantages that can be gained when adopting a new protocol.
This article reviews factors that affect protein stability at different steps of the product manufacturing process and strategies to minimize their impact on product quality.
Perfusion processes can attractive for biologics drug manufacturing; however, obstacles remain.
An in-depth characterization of maize-derived trypsin revealed an unusual nonconsensus N-linked glycosylation.
Newer classes of biotherapies will require innovations in processing technology.
A case study evaluates the performance, control of operations, productivity, and cost savings of a single-use system.
Supply-chain analytics can lead to increased profitability.
The control of biologics microbiological impurities, contaminants, and mimetics is evolving.
Apply a DoE strategy to test several formulations in parallel.
The little-known exception to the patent term extension law is potentially valuable but easy to miss.